Former Chief Therapeutics Officer · 23andMe Holding Co. (ME)

Kenneth Hillan

A named executive officer of 23andMe in every fiscal year CompBrief holds from FY2022 to FY2024. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2024

$1,327,001

FY2022: $3,201,858

Compensation figures as of the proxy filed July 16, 2024 (DEF 14A).

Kenneth Hillan compensation by year

23andMe Summary Compensation Table · all 2 fiscal years held
In US dollars, as 23andMe reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2022FY2024
Salary$578,333$529,058
Bonus$0$0
Stock awards$1,070,455$0
Option awards$1,549,205$793,563
Non-equity incentive$0$0
Pension and deferred compensation$0$0
All other$3,865$4,381
Total$3,201,858$1,327,001

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: 23andMe Holding Co. DEF 14A filed July 16, 2024, accession 0001140361-24-033309, and prior-year filings. Open the filing on EDGAR.

$3.2M
$1.3M
FY22
FY24
SalaryStock awardsOption awardsAll other

Change-in-control & termination

estimated payments 23andMe discloses, by trigger · FY2022
TriggerCash severanceAccelerated equityBenefits continuationTotal as disclosed
Death$0$0$0$0
Change in control and involuntary termination$307,500$0$0$307,500
Involuntary termination without cause$307,500$0$0$307,500
Disability$0$0$0$0
Voluntary resignation$0$0$0$0

Per the Potential Payments Upon Termination or Change in Control table in 23andMe Holding Co.'s FY2022 proxy. Estimates as the company printed them; a dash means it printed no figure.

23andMe’s named executive officers, FY2024

as the company reported each
Named executive officerRoleFY2024 total
Anne WojcickiChief Executive Officer$7,363,723
Joseph SelsavageChief Financial and Accounting Officer$2,133,227
Kathy HibbsFormer Chief Administrative Officer$2,119,783
William RichardsHead of Therapeutics Discovery$1,461,868
Kenneth Hillan · this pageFormer Chief Therapeutics Officer$1,327,001

The full 23andMe compensation record

free company brief

This page is one person within 23andMe's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order 23andMe's full Executive Compensation Report with peer benchmarking.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are 23andMe's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Velarion Pro: every company page, peer tools and exports, one seat

One email to you when Pro opens, and nothing else. Privacy